Connect with us

Global Affairs

Canada should focus on abortion access not legislation, advocates say | Global development

Voice Of EU

Published

on

Abortion advocates are warning that the recent US supreme court ruling overturning Roe v Wade will empower anti-choice groups in Canada to push for restricted access, making a settled matter appear controversial in a country where nearly 80% of people are pro-choice.

A key anti-choice strategy in Canada revolves around enacting abortion legislation – an idea that has been gaining traction amid the fallout of the US court ruling. There is currently no abortion law in Canada, making it the only country in the world where the procedure is totally free of legal restrictions.

“There’s a lot of talk right now about whether or not the Canadian government should pass a proactive law protecting our right to abortion – a pre-emptive strike, if you will. That would be a big mistake,” said Daphne Gilbert, a law professor at the University of Ottawa.

Gilbert and other abortion advocates say that while enshrining abortion rights may sound progressive, the opposite is true: consolidating rules would make it easier for anti-choice legislators to retract abortion rights if ever they found themselves in a majority. Last year, 81 Conservative MPs (and one independent) voted for anti-choice legislation.

And while the prime minister, Justin Trudeau, promised Canadians after Roe that his government would “always stand up for your right to choose”, advocates argue that may not always be true.

That’s why the country should focus on entrenching people’s rights by expanding abortion access, said Gilbert.

Since it became legal in a 1988 supreme court ruling, abortion in Canada has been designated as a medical service like any other, on par with procedures like X-rays and blood tests. But that doesn’t make it easy to get – especially in remote, religious or conservative parts of the country.

In 2014, Sarah (who asked to remain anonymous) sought an abortion on Prince Edward Island (PEI) – a province of 30,000 that, at the time, did not have a single publicly operating abortion provider.

It took Sarah a month to finally secure a provider – five hours away, in another province. The trip incurred travel and lodging costs, but the procedure itself was covered by the healthcare authority.

“The idea that anybody has to travel to take care of something that you should be able to get done close to home – it’s not fine,” said Sarah. Abortion care only arrived on PEI in 2017, after activists sued the provincial government for acting unconstitutionally.

Although there is no federal law, each province’s medical college sets its own guidelines on abortion, including gestational age limits for use of the abortion pill.

Those guidelines are shaped by the skills and training available in each province, said Martha Paynter, an abortion care provider in Nova Scotia and the author of the new book Abortion to Abolition: Reproductive Health and Justice in Canada.

But there is also a political dimension to providing abortion care that prevents some doctors and nurse practitioners from taking it up.

“More people could be doing it than are doing it,” said Paynter. “We as educators – I’m a prof at a nursing school – have the responsibility to teach in every medical and nursing program how to do this care, and hardly [any school] does it.”

Paynter is the creator of the country’s first university abortion course, at Dalhousie University, which is open to students across medical, nursing and other health programs with the purpose of inspiring future health workers to integrate abortion access into primary care.

The Society of Obstetricians and Gynaecologists offers an online course to teach professionals how to prescribe and manage medical abortion.

But most students and healthcare professionals are not required to learn about how medication and surgical abortion work – and many choose to abstain because they are afraid to enter the political fray around abortion.

According to Gilbert, that means a lot of primary care providers stay wilfully uninformed.

“A lot of doctors just aren’t political people. They’re scientists, and they don’t see the politics behind some of their care,” she said.

Further complicating access is the fact that many Canadians are unaware that nurse practitioners in the country are permitted to prescribe the abortion pill and refer patients to surgical abortion providers – or that most patients can self-refer directly to an abortion provider.

Addressing these issues is critical to expanding existing access to medication and surgical abortion, said Paynter and Gilbert.

In 2017, Natalie (also a pseudonym) discovered she was pregnant while visiting her parents in a small town in northern Alberta. After one doctor at a local walk-in clinic told her abortion was murder, she demanded an appointment with a different doctor.

That doctor told her that there was no such thing as medical abortion. “He looked me in the face and said, ‘That doesn’t exist,’” she said.

Mifegymiso – otherwise known as the abortion pill – was approved by Health Canada in 2015, but had only recently hit the market when Natalie found herself at the doctor’s office.

“I know it exists. It’s literally the front page of the news,” she told him.

Still, she went away empty-handed. She was only able to get an abortion after returning to her home province of New Brunswick, where only three hospitals and one clinic provide abortion. Natalie went to the clinic, where she paid $800 for a surgical abortion – a cost incurred because the province refuses to pay for abortions performed outside of hospitals.

New Brunswick is currently being sued for its restriction of abortion.

Stories like those of Sarah and Natalie show how abortion remains inaccessible in Canada, despite its federal legal standing.

“Our greatest problems really come in terms of provinces and what they may do to restrict access to abortion in light of what I think is now going to be a really emboldened anti-choice movement,” said Gilbert.

Source link

Global Affairs

Brazilian woman and fake seer con elderly mother out of $142 million | International

Voice Of EU

Published

on

A woman was arrested on August 10 by Rio de Janeiro police who charged her with conning her mother out of millions. In a strange story of greed abetted by fake psychics, Sabine Boghici and her accomplices stole more than $142 million in money, jewelry and artwork from Boghici’s mother over a two-year period.

Geneviève Boghici, the widow of a major art collector and dealer named Jean Boghici, was walking out of a bank in January 2020 near the famous Copacabana Beach in Rio de Janeiro (Brazil) when she was approached by a supposed psychic prophesying her daughter’s imminent death unless she underwent “spiritual therapy.” They walked together to Boghici’s apartment, where the psychic threw some shells in a mystical ritual that confirmed the tragic prophesy. The 82-year-old victim knew that her daughter suffered from psychological problems, and her affinity for the supernatural swayed her to transfer $980,000 to the swindlers.

Soon after the two-year con began, the elderly woman became suspicious and halted the money transfers when her daughter started to isolate her from friends. Sabine would not allow her mother to use the phone and dismissed all the domestic workers, justifying them as Covid-19 precautions. Yet Sabine and her cronies entered freely to loot her mother’s home of its valuables. Several psychics took items from the home, saying they were “cursed” and needed to be “prayed over.” The increasingly suspicious Geneviève tried to resist, but Sabine began threatening her life. According to the police, she wouldn’t allow her mother to eat and put a knife to her throat.

Police recover 'Sol Poente' by Brazilian painter, Tarsila do Amaral.
Police recover ‘Sol Poente’ by Brazilian painter, Tarsila do Amaral.Policia Civil de Rio de Janeiro (EFE)

The victim told the police that her daughter had some sort of relationship with one of the supposed psychics, Rosa Stanesco Nicolau, who practiced her trade in Rio de Janeiro as “Mãe Valéria de Oxossi” (Mother Valeria), and was a known con artist. Starting in September 2020, under constant threat from her daughter and accomplices, the elderly woman made another 38 bank transfers to the thieves.

Sabine and her cohorts stole 16 paintings and sculptures, and sold them all to art galleries or private buyers. Two of these works – Elevador Social (Social Elevator) by Rubens Gerchman, and Maquete para o menú espelho (A model for my mirror) by Antonio Dias – were bought by Eduardo Costantini, owner of the Museum of Latin American Art of Buenos Aires (Argentina), for his private collection. The São Paulo (Brazil) gallery owner who brokered the deal said he was not suspicious because he had known the family for a long time and the seller was the daughter of the deceased art collector. Constantini released a statement saying that he bought the paintings in good faith and was in direct contact with Genevieve Boghici.

In 2012, a fire in the Boghici’s Copacabana apartment destroyed part of their valuable collection, including Di Cavalcanti’s Samba and Alberto Guignard’s A Floresta (The Forest). Sol Poniente (Setting Sun), painted by Tarsila do Amaral in 1929, is one of the most valuable works in the Boghici collection ($49 million). It survived the 2012 fire but not the rampant greed of their daughter. The stolen painting was found under a bed by police, who arrested Sabine and three other people, including the fake seer. In a final twist to the whole bizarre story, the scamming psychic was apprehended trying to escape through a window.

Source link

Continue Reading

Global Affairs

India’s HIV patients say shortages leaving hundreds of thousands without drugs | Global development

Voice Of EU

Published

on

Hundreds of thousands of people living with HIV in India are struggling to access treatment because of a shortage of antiretroviral (ARV) drugs, according to campaigners.

Up to 500,000 people have not been able to get hold of free ARVs from government health centres and hospitals over the past five months, they say, as the country experiences stock shortages of key drugs.

ARVs that are available in privately run pharmacies and shops can be prohibitively expensive. Some people have been given alternative drugs, but others have stopped taking any medication.

“Does the government even realise that at least 500,000, or one-third of the patients, are affected by this? Some adults are being given 11 doses of paediatric medicine to compensate,” said Loon Gangte, president of the Delhi Network of Positive People (DNP+), an NGO that works to improve the treatment and facilities for people living with HIV and Aids. “We only demand an uninterrupted monthly supply. This treatment is our right.”

According to Gangte, who has been protesting with about 30 others outside India’s National Aids Control Organisation (Naco) in Delhi for 22 days, at least 12 other states, including Assam, Uttar Pradesh, Rajasthan and Punjab, are facing ARV shortages. He said several state governments have asked patients to change their longstanding drug regimes.

“The [Covid-19] pandemic had already broken our backs. Now this shortage is pushing us further into penury,” Gangte said.

Kedar Nath, a 30-year-old street vendor taking part in the protest, said he has not taken his ARVs on several occasions over the past two months. He cannot afford the £50 a month it would cost to buy the drugs on the open market.

“I have been taking these drugs for the last 13 years. They have helped me continue with my life despite the virus in my body. But the recent shortage has turned my life upside down since I can neither find the strength to work, nor have any savings to live off,” he said.

According to government figures, 2.35 million people in India are HIV-positive. About 1.5 million people are on antiretroviral therapy, far lower than the World Health Organization’s “90-90-90 target” – under which 90% of people with HIV are diagnosed, 90% are on ARV treatment, and 90% are no longer infectious.

India says it aims to end the HIV epidemic by 2030. In 2019, an estimated 58,900 Aids-related deaths were reported in the country.

The government has refuted Gangte’s claims of a shortage. The Indian health ministry said it had “reviewed the entire situation and held a series of meetings with the protesters. ARV drugs are being provided for [a] duration of less than one month, but at no point in time has there been any shortage of drugs for any of the PLHIV [patients living with HIV]. There is adequate stock nationally for 95% PLHIV.”

Naco did not wish to comment. However, in a letter seen by the Guardian that was dated 30 May, Naco asked all state Aids prevention and control societies, which oversee HIV testing and treatment in each state, to switch to other regimes “to tide through the crisis situation as an interim arrangement”.

Sign up for a different view with our Global Dispatch newsletter – a roundup of our top stories from around the world, recommended reads, and thoughts from our team on key development and human rights issues, delivered to your inbox every two weeks:

Sign up for Global Dispatch – please check your spam folder for the confirmation email

Source link

Continue Reading

Global Affairs

J&J Stops Global Sales of Scandalous Talc-Based Powder After 130 Years

Voice Of EU

Published

on

https://sputniknews.com/20220812/jj-stops-global-sales-of-scandalous-talc-based-powder-after-130-years-1099524790.html

feedback@sputniknews.com

+74956456601

MIA „Rosiya Segodnya“

2022

Tim Korso

https://cdnn1.img.sputniknews.com/img/07e6/03/0d/1093831826_0:0:216:216_100x100_80_0_0_e3f43a960af0c6c99f7eb8ccbf5f812c.jpg

Tim Korso

https://cdnn1.img.sputniknews.com/img/07e6/03/0d/1093831826_0:0:216:216_100x100_80_0_0_e3f43a960af0c6c99f7eb8ccbf5f812c.jpg

News

en_EN

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rosiya Segodnya“

https://cdnn1.img.sputniknews.com/img/107521/29/1075212912_0:211:3030:2484_1920x0_80_0_0_485148bce02446b42edc0b28f2667d83.jpg

Sputnik International

feedback@sputniknews.com

+74956456601

MIA „Rosiya Segodnya“

business, johnson & johnson

Subscribe

International
India

Once one of its top products for families, J&J’s talc-based powder has been haunted by claims of causing cancer in recent years even as the company consistently denied what it has called rumors and “misinformation”.

Johnson & Johnson has announced it will be ceasing the sales of its talc-based powder, two years after stopping them in the US and Canada, after keeping it in its product line for 130 years. The company will be replacing the product with a cornstarch-based powder.

“As part of a worldwide portfolio assessment, we have made the commercial decision to transition to an all cornstarch-based baby powder portfolio,” the company’s statement said.

The J&J talc-based powder has been at the epicenter of several lawsuits claiming it caused ovarian cancer due to the presence of a known cancer-causing material – asbestos. However, the company has repeatedly denied these allegations, despite losing $3.5 billion in these lawsuits.

As the firm announced the retirement of the talc-based powder, it once again repeated its long-held position on the controversial product’s safety.

“Our position on the safety of our cosmetic talc remains unchanged. We stand firmly behind the decades of independent scientific analysis by medical experts around the world that confirms talc-based Johnson’s baby powder is safe, does not contain asbestos, and does not cause cancer,” the statement said.

Apart from losing a number of lawsuits, J&J faced tough questions following a 2018 Reuters investigation, which claimed the company knew about the asbestos contamination since at least 1971 but failed to act on it. As the veins of asbestos are often found in talc deposits, the extracted talc used to make the powder can be contaminated with the cancer-causing mineral.

A view of the Supreme Court in Washington, U.S. January 19, 2021 - Sputnik International, 1920, 01.06.2021

Pay Up: Supreme Court Rejects J&J’s Request to Appeal $2 Bln Verdict in Talc Cancer Case
Despite continuing to maintain its innocence, J&J stopped selling talc-based powder in the US and Canada in 2020, citing the harm done to the sales by the “misinformation” about its safety. However, the company continued to distribute it around the world alongside the cornstarch-based alternative, which will now completely substitute it.



Source link

Continue Reading

Trending

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates 
directly on your inbox.

You have Successfully Subscribed!